Saghir Akhtar

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Gene-edited hypoimmune islets as a cure for type 1 diabetes: a review of the immunological challenges.

Gene-edited hypoimmune islets as a cure for type 1 diabetes: a review of the immunological challenges.

Journal: Expert opinion on biological therapy

Published: August 21, 2026

Red blood cells in prediabetes: Early alterations, progressive trajectories, and clinical potential.

Red blood cells in prediabetes: Early alterations, progressive trajectories, and clinical potential.

Journal: Diabetes research and clinical practice

Published: July 06, 2026

Biased agonists for the treatment of type 2 diabetes and obesity: a novel pharmacological paradigm edging closer to clinical reality?

Biased agonists for the treatment of type 2 diabetes and obesity: a novel pharmacological paradigm edging closer to clinical reality?

Journal: Journal of drug targeting

Published: April 11, 2026

Beyond oxygen transport: red blood cells as emerging players in mediating endothelial dysfunction in diabetes.

Beyond oxygen transport: red blood cells as emerging players in mediating endothelial dysfunction in diabetes.

Journal: Annals of medicine

Published: April 03, 2026

Low-dose metformin in the brain: A focused review of its novel mechanism of glucose lowering in type 2 diabetes.

Low-dose metformin in the brain: A focused review of its novel mechanism of glucose lowering in type 2 diabetes.

Journal: Biomolecules & biomedicine

Published: March 06, 2026

Angiotensin-(1-7) in asthma and pulmonary fibrosis: mechanisms of action, clinical safety, and nano-delivery strategies.

Angiotensin-(1-7) in asthma and pulmonary fibrosis: mechanisms of action, clinical safety, and nano-delivery strategies.

Journal: Frontiers in pharmacology

Published: January 17, 2026

Attenuating amygdalin (vitamin B17) toxicity for potential therapeutic uses: insights into controlled release technology-based formulations as a strategy for improving clinical safety.

Attenuating amygdalin (vitamin B17) toxicity for potential therapeutic uses: insights into controlled release technology-based formulations as a strategy for improving clinical safety.

Journal: Expert opinion on drug delivery

Published: October 02, 2025

HDL attenuates Ang II-AT1R-EGFR signaling and reverses vascular remodeling in spontaneously hypertensive rats.

HDL attenuates Ang II-AT1R-EGFR signaling and reverses vascular remodeling in spontaneously hypertensive rats.

Journal: Frontiers in pharmacology

Published: April 24, 2025

Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future.

Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future.

Journal: Biomolecules & biomedicine

Published: February 17, 2025

The impact of COVID-19 on the mental health of dental students at an Australian school.

The impact of COVID-19 on the mental health of dental students at an Australian school.

Journal: Australian dental journal

Published: May 27, 2024

The cardiac toxicity of PAMAM dendrimer drug delivery systems can be attenuated with the adjunct use of cardioprotective agents.

The cardiac toxicity of PAMAM dendrimer drug delivery systems can be attenuated with the adjunct use of cardioprotective agents.

Journal: Biomolecules & biomedicine

Published: May 13, 2024

Confidence in Prescribing Practices: Perspectives of Senior Medical Students and Recent Graduates at Qatar University.

Confidence in Prescribing Practices: Perspectives of Senior Medical Students and Recent Graduates at Qatar University.

Journal: Advances in medical education and practice

Published: April 30, 2024

Showing 1-12 of 68

Last Updated: 09/26/2026